1-20 of 386 results for answeredby:"James Frith"
Librarians' tools
- Search time
- 0.241 seconds
- Solr query time
- 0.003 seconds
- Search query
- answeredby:"James Frith"
- We searched for
- answeringMember_ses:437165 OR answeringDept_ses:437165 OR askedToReplyAuthor_ses:437165
Type
House
Session
Year
Department
Member
More
Primary member
More
Answering member
Legislative stage
Legislation
Subject
More
Publisher
To ask the Secretary of State for Health and Social Care, what assessment she has made of access to cardiac screening for first-degree relatives following a death attributed to Sudden Arrhythmic Death Syndrome (SADS).
To ask the Secretary of State for Health and Social Care, what assessment she has made of access to cardiac screening for first-degree relatives following a death attributed to Sudden Arrhythmic Death Syndrome (SADS).
I refer the Hon Member to the answer provided on 14 January in response to Question 100691.
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to prioritise access to special treatment for patients with rare cancers such as lymphoma and expand access to specialist expertise.
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to prioritise access to special treatment for patients with rare cancers such as lymphoma and expand access to specialist expertise.
I refer the Hon Member to the answer provided on 17 July 2026 in response to Question 18279.
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of integrating evidence-based nutritional, physical activity and lifestyle interventions more routinely alongside medical treatment for cancer patients.
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of integrating evidence-based nutritional, physical activity and lifestyle interventions more routinely alongside medical treatment for cancer patients.
I refer the Hon Member to the Department’s strategy on Living with and Beyond Cancer in Chapter 4 of the National Cancer Plan available at the link below, which examines these and other issues in detail:
To ask the Secretary of State for Health and Social Care, if she has made an assessment of the potential (a) financial and (b) other challenges faced by cancer patients in accessing appropriate evidence-based nutritional, lifestyle and wellbeing support alongside their treatment.
To ask the Secretary of State for Health and Social Care, if she has made an assessment of the potential (a) financial and (b) other challenges faced by cancer patients in accessing appropriate evidence-based nutritional, lifestyle and wellbeing support alongside their treatment.
I refer the Hon Member to the Department’s strategy on Living with and Beyond Cancer in Chapter 4 of the National Cancer Plan available at the link below, which examines these and other issues in detail:
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to ensure that funding decisions for brain tumour research reflect the prevalence and clinical impact of low-grade glioma.
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to ensure that funding decisions for brain tumour research reflect the prevalence and clinical impact of low-grade glioma.
Some of the data requested by the Hon. Member is not centrally held, but on the wider issues raised, I refer him to the answer provided on 3 March in response to Question 115098. Available data on this issue is also published by the National Institute for Health and Care Research at the following link:
To ask the Secretary of State for Health and Social Care, what criteria NHS England and her Department use to select and prioritise technologies for consideration under the National Health Tech Access Programme.
To ask the Secretary of State for Health and Social Care, what criteria NHS England and her Department use to select and prioritise technologies for consideration under the National Health Tech Access Programme.
I refer the Hon. Member to Annex A of the National Institute for Health and Care Excellence Topic Selection Manual, published on 25 August, which is available at the following link:
https://www.nice.org.uk/process/pmg46/chapter/annex-a-national-healthtech-access-programme
To ask the Secretary of State for Health and Social Care, which technologies are being considered for prioritisation under the National Health Tech Access Programme.
To ask the Secretary of State for Health and Social Care, which technologies are being considered for prioritisation under the National Health Tech Access Programme.
I refer the Hon. Member to Annex A of the National Institute for Health and Care Excellence Topic Selection Manual, published on 25 August, which is available at the following link:
https://www.nice.org.uk/process/pmg46/chapter/annex-a-national-healthtech-access-programme
To ask the Secretary of State for Health and Social Care, what specific diversity and inclusion (a) days, (b) weeks and (c) months, were recognised and marked by (i) the department and (ii) NHS England, in the calendar year 2025.
To ask the Secretary of State for Health and Social Care, what specific diversity and inclusion (a) days, (b) weeks and (c) months, were recognised and marked by (i) the department and (ii) NHS England, in the calendar year 2025.
The requested information is not held centrally by the Department and could only be collated and verified at disproportionate cost.
To ask the Secretary of State for Health and Social Care, what recent discussions her Department has had with (a) patients and (b) medical professionals on increasing (i) investment and (ii) clinical trials into cancer treatments.
To ask the Secretary of State for Health and Social Care, what recent discussions her Department has had with (a) patients and (b) medical professionals on increasing (i) investment and (ii) clinical trials into cancer treatments.
I refer the Hon Member to the National Cancer Plan for England, published in February, which sets out the steps we are taking in a range of areas to improve cancer diagnosis, treatment, and outcomes, including for research and clinical trials. The National Cancer Plan for England is available at the following link:
I also refer the Hon Member to the answer provided on 24 February 2026 to the Hon Member for Sheffield South East to Question 113042.
To ask the Secretary of State for Health and Social Care, what recent steps her Department has taken to increase funding for cancer research.
To ask the Secretary of State for Health and Social Care, what recent steps her Department has taken to increase funding for cancer research.
I refer the Hon Member to the National Cancer Plan for England, published in February, which sets out the steps we are taking in a range of areas to improve cancer diagnosis, treatment, and outcomes, including for research and clinical trials. The National Cancer Plan for England is available at the following link:
I also refer the Hon Member to the answer provided on 24 February 2026 to the Hon Member for Sheffield South East to Question 113042.
To ask the Secretary of State for Health and Social Care, what recent assessment she has made of the adequacy of availability of NHS specialist clinics for people with Postural Tachycardia Syndrome.
To ask the Secretary of State for Health and Social Care, what recent assessment she has made of the adequacy of availability of NHS specialist clinics for people with Postural Tachycardia Syndrome.
I refer the Hon. Member to the answer provided on 15 June in response to Question 6594.
Departmental officials meet on a regular basis with patient organisations, integrated care boards and other stakeholders to discuss the improvement of National Health Service care for a range of conditions. External meetings of that nature held by ministers and senior officials are reported on a quarterly basis in the Department’s transparency publications.
To ask the Secretary of State for Health and Social Care, what recent assessment has been made of regional variation in access to specialist services for people with Postural Tachycardia Syndrome.
To ask the Secretary of State for Health and Social Care, what recent assessment has been made of regional variation in access to specialist services for people with Postural Tachycardia Syndrome.
I refer the Hon. Member to the answer provided on 15 June in response to Question 6594.
Departmental officials meet on a regular basis with patient organisations, integrated care boards and other stakeholders to discuss the improvement of National Health Service care for a range of conditions. External meetings of that nature held by ministers and senior officials are reported on a quarterly basis in the Department’s transparency publications.
To ask the Secretary of State for Health and Social Care, if she will make an estimate of the number of hours spent (a) responding to and (b) preparing for Westminster Hall Debates by (i) government ministers, (ii) civil servants and (iii) special advisers in her Department for each parliamentary...
To ask the Secretary of State for Health and Social Care, if she will make an estimate of the number of hours spent (a) responding to and (b) preparing for Westminster Hall Debates by (i) government ministers, (ii) civil servants and (iii) special advisers in her Department for each parliamentary...
I refer the Hon. Member to the answer given on 16 July 2026 to Question 17477.
To ask the Secretary of State for Health and Social Care, whether her Department plans to pilot the provision of NT-proBNP point-of-care testing in community pharmacies for people presenting with symptoms of heart failure.
To ask the Secretary of State for Health and Social Care, whether her Department plans to pilot the provision of NT-proBNP point-of-care testing in community pharmacies for people presenting with symptoms of heart failure.
On the provision of NT-proBNP point-of-care testing, I refer the Hon. Member to the answer provided on 5 June 2025 in response to Question 54244. More broadly, the Cardiovascular Diesease Modern Service Framework sets out the Department's approach to prevention and reduced hospital admissions and is available at the following link:
https://www.gov.uk/government/publications/cardiovascular-disease-modern-service-framework
However, the Department does not hold the specific estimate requested.
To ask the Secretary of State for Health and Social Care, what assessment her department has made of the potential impact of funding for earlier diagnosis and specialist heart failure services on NHS expenditure associated with emergency admissions.
To ask the Secretary of State for Health and Social Care, what assessment her department has made of the potential impact of funding for earlier diagnosis and specialist heart failure services on NHS expenditure associated with emergency admissions.
On the provision of NT-proBNP point-of-care testing, I refer the Hon. Member to the answer provided on 5 June 2025 in response to Question 54244. More broadly, the Cardiovascular Diesease Modern Service Framework sets out the Department's approach to prevention and reduced hospital admissions and is available at the following link:
https://www.gov.uk/government/publications/cardiovascular-disease-modern-service-framework
However, the Department does not hold the specific estimate requested.
To ask the Secretary of State for Health and Social Care, whether guidance is available to NHS cancer services on providing patients with evidence-based information on nutrition, physical activity and lifestyle alongside conventional cancer treatment.
To ask the Secretary of State for Health and Social Care, whether guidance is available to NHS cancer services on providing patients with evidence-based information on nutrition, physical activity and lifestyle alongside conventional cancer treatment.
I refer the Hon Member to the Department’s strategy on Living with and Beyond Cancer in Chapter 4 of the National Cancer Plan available at the link below, which examines these and other issues in detail:
To ask the Secretary of State for Health and Social Care, how much her Department spent on activities relating to Pride Month 2026.
To ask the Secretary of State for Health and Social Care, how much her Department spent on activities relating to Pride Month 2026.
The Department did not incur any spend associated with or linked to Pride Month 2026.
To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact of a delayed diagnosis of Inflammatory Bowel Disease on A&E capacity over the past 12 months.
To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact of a delayed diagnosis of Inflammatory Bowel Disease on A&E capacity over the past 12 months.
The Department does not hold the specific information the Hon. Member has requested, but on the wider issue of diagnosis and treatment for these conditions, I refer him to the answer provided on 27 May in response to Question 2655.
To ask the Secretary of State for Health and Social Care, what data her Department holds on the number and proportion of people with Crohn’s Disease or Ulcerative Colitis diagnosed following an A&E attendance, emergency hospital admission, or emergency surgery over the past 12 months.
To ask the Secretary of State for Health and Social Care, what data her Department holds on the number and proportion of people with Crohn’s Disease or Ulcerative Colitis diagnosed following an A&E attendance, emergency hospital admission, or emergency surgery over the past 12 months.
The Department does not hold the specific information the Hon. Member has requested, but on the wider issue of diagnosis and treatment for these conditions, I refer him to the answer provided on 27 May in response to Question 2655.
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to expand access to clinical trials for (a) pancreatic cancer patients and (b) patients with cancerous brain tumours.
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to expand access to clinical trials for (a) pancreatic cancer patients and (b) patients with cancerous brain tumours.